Latest Content

Jessica Steen, OD, FAAO, DipABO, weighs in on what the optometric community should know concerning what side effects their patients may experience.

A summary of major FDA approvals and CRLs in eye care from the first half of 2026.

Host Hamza Shah, OD, MS, FAAO, is joined by Brianna Rhue, OD, FAAO, to discuss eye care terminology, inspired by Zhang et al's paper, "Myopia Progression Management: Current Trends and Future Directions."

An overview of the diagnosis and evidence-based management of one of the most common causes of visual acuity reduction following intraocular surgery.

In a preference study, Karl Csaky, MD, PhD and colleagues found that lesion growth rate reduction was the primary driver of GA treatment decisions among US retina specialists, with greater risk tolerance for foveal-threatening lesions.

Jessilin Quint, OD, MBA, FAAO, said that integrating AI into your practice can start small.

A large real-world cohort study by Takashi Nishida, MD, PhD et al finds OSA is associated with elevated glaucoma risk.

According to the survey, one in five sufferers reported that dry eye symptoms affect their self-confidence (22%) and emotional wellbeing (20%).

Shareen M. Greenbaum, MD, and Amanda Amberg, OD, recognize comanagement as an opportunity to target dry eye early and use advanced diagnostics and treatments for healthier ocular surfaces.

In this podcast, retina specialist John Kitchens, MD, has a conversation with a patient about the choice he made for anti-VEGF therapy to reduce his treatment burden, then discusses recent clinical trial data on therapeutic options with extended treatment intervals.

Kaleb Abbott, OD, MS, FAAO, FOWNS, details one of his lectures during AOA's Optometry's Meeting 2026.

Jacqueline Theis, OD, FAAO, gave tips to clinicians on how to critically read studies in order to assess if they are applicable to their everyday practice.

Denise Whittam, OD, said that the Acuvue Oasys lens family holds her go-to lenses for patients for their comfortability.